President Uhuru Kenyatta  has today in State House, Nairobi witnessed the signing of a memorandum of understanding between Kenya and Moderna to establish the first mRNA manufacturing facility in Africa.
The state-of-the-art mRNA facility in Africa is expected to produce up to 500 million doses of vaccines each year.
The Company anticipates investing up to $500 million in the new facility, which will focus on drug substance manufacturing on the continent of Africa for the continent of Africa.

The President pointed out that the setting up of the mRNA manufacturing facility will be a game changer especially for Kenya who has had a vision to produce vaccines.

“We are celebrating one of the greatest things  that has possibly happened since the onset of COVID-19 at the African continent,” said President Kenyatta when he spoke.

The President reiterated the challenges faced by the African continent during the COVID-19 pandemic. This was not because of lack of finances to  buy the vaccines but because the vaccines were not available for them for purchase.

The President thanked Moderna company for coming up to fill the space which made the continent suffer in meeting its vaccines needs saying the new facility will go along way in enabling African countries tackle any emerging future pandemics.

“We all know the challenges that Kenya and the entire continent of Africa went through in the earlier stages of this pandemic that resulted in Africa being left behind. Not because of want but  because of lack and Moderna  has come to fill that space.

“We are truly grateful, for this and I think it will be transformative not just in helping us with the current pandemic but also preparing the continent of Africa for future pandemics,” President Kenyatta said.

Moderna’s Chief Executive Officer Stéphane Bancel  said  his company is committed to partnering  to provide a health solution saying the investment the company is making in Kenya is crucial as it is part of the solution to ensuring  global health equity.

The President thanked the Director for  Africa Centre for Disease Control Dr. John Nkengasong and the Government of America for supporting Kenya in  its endeavor to set up the facility.